Background: Acute deep venous thrombosis (DVT) responds favorably to various thrombectomy devices including Trellis (Covidien). In patients with an IVC filter, occasionally massive bilateral DVT may occur with frequent involvement of the filter. The role of Trellis in the treatment of IVC filter thrombosis (IVCFT) has not been investigated. Methods: Fifty two patients with IVCFT underwent treatment with Trellis as part of the percutaneous endovenous intervention (PEVI) strategy (Fig.1 ). All had bilateral lower extremity and iliac DVT and were quite symptomatic. For initial treatment an 8 F Trellis system was used in all with administration of 10 mg of tPA via the Trellis catheter. The device was activated inside the filter.Following the procedure venography was obtained to assess the outcome.
Results:
No patient achieved complete resolution of IVCFT with Trellis thrombectomy alone. Partial resolution was achieved in only 8 patients. The remaining 44 patients had no meaningful improvement and required catheter-directed thrombolysis (CDT) with tPA for a mean duration of 32Ϯ8 hours. With CDT complete or substantial resolution of IVCFT was achieved. There was no symptomatic pulmonary embolism as a result of PEVI. Conclusions: IVCFT is associated with bilateral iliac and femoropopliteal DVT. Trellis thrombectomy alone has a limited role in its management and most patients require CDT.
TCT-757
Rapid resolution of right ventricular dysfunction using ultrasonic thrombolysis in massive and submassive pulmonary embolism patients This study assesses the hemodynamic effects of ultrasound accelerated thrombolysis (USAT), an emerging catheter-based modality, among these patients in resolving the thrombus and restoring cardiopulmonary function. Methods: We retrospectively evaluated consecutive PE patients treated using USAT (EkoSonic Endovascular System, EKOS Corporation) with recombinant tPA at East Jefferson General Hospital from 2009 to 2011. All patients presented with signs of acute PE and received chest CT scans for confirmation of PE. Follow-up CT was performed at 39Ϯ23 hours after USAT. RV dysfunction was characterized by the right-to-left ventricular dimension (RV/LV) ratio. Thrombus burden was assessed using the modified Miller Score. All CT measurements were performed by an independent core laboratory. Results: Among the 42 patients (age 58Ϯ16 yrs) evaluated, 7 were massive and 35 were submassive PE cases. 37 patients (88%) presented with bilateral PE. Overall, the mean tPA dose was 31.0Ϯ16.6 mg infused over 19.0Ϯ6.8 hours. Following USAT, the RV/LV ratio was reduced from 1.48Ϯ0.42 to 0.96Ϯ0.18 (pϽ.001) and the modified Miller Score from 18.0Ϯ5.1 to 9.7Ϯ5.3 (pϽ.001) at follow-up CT. Patients treated early in the series (nϭ13) using a total dose of ϳ45 mg tPA did not show greater reduction in RV/LV ratio or Miller Score than those later in the series (nϭ29) using a total dose of ϳ20 mg tPA (pՆ.38). Median length of stay was 1 day in the ICU and 7 days in the hospital. All patients were discharged alive. There were no systemic bleeding complications, but 4 access site bleeding complications requiring transfusion and 1 suspected recurrent massive PE event, all reported in the higher tPA dose group. Conclusions: For massive and submassive PE, treatment by USAT rapidly reduced RV dilatation and pulmonary clot burden with minimal risk of bleeding, allowing restoration of cardiopulmonary function. 
TCT-758 Percutaneous Thrombectomy with Right Coronary Judkins 8 French Guide Catheter for the Treatment of High Risk Acute Pulmonary Embolism

Medstent, Mexico City, Mexico
Background: Acute high risk pulmonary embolism carries a high degree of morbidity/ mortality and proper and rapid actions must be taken, this study aims to demonstrate how to recover the patency of the pulmonary arteries by thrombus aspiration with right coronary guide catheter in order to improve the function of the right ventricle and reduce mortality. Methods: A total of 38 patients, 20 female, 18 male, ages 28 to 64 years with high risk acute pulmonary embolism were studied from March 2009 to April 2012. In all patients the pulmonary obstruction was bilateral, the degree of obstruction was greater than 80% of the main branches. The diagnosis was formulated with pulmonary angiotomography echocardiogram. By percutaneous puncture of the femoral vein an 8 French by 80cm in length metal sheath was advanced to the trunk of the pulmonary artery, a #4 Judkins right coronary guide catheter was advanced trough the introducer to the site of thrombosis and a 20ml syringe connected and vacuum sustained trough the catheter while slowly withdrawing it, subsequently the catheter was extracted and purged to extract the aspirated thrombi. This maneuver was repeated several times and finally angiography with this catheter was perform to confirm the patency of the pulmonary branches. Results: Extraction of thrombus was achieved in all cases. permeability of the pulmonary branches was obtained in 80% of the cases, saturation and blood pressure were restored in the next few hours. One patient (2.63%) died during the procedure and another patient had hemoptysis. Conclusions: This is an effective technique for the treatment of high-risk acute pulmonary embolism reproducible at low-cost and capable to reestablish blood pressure, oxygen saturation and right ventricular function and decrease morbidity significantly. 
TCT-759
Ultrasound-Accelerated Thrombolysis for the Treatment of Acute Pulmonary Embolism
Matthew
University of Kentucky, Lexington, KY
Background: Acute pulmonary embolism (PE) is a major cause of death. 90-day mortality rates are 58% for massive PE (with cardiogenic shock) and 22% for submassive PE (right heart strain without shock). Systemic thrombolysis improves hemodynamic stability but is associated with major bleeding in 20% of patients. Alternative therapies for acute PE are needed. This study examines the safety and effectiveness of catheter-directed, ultrasound-accelerated thrombolysis (USAT) in patients with PE. 
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